Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Harvard Business School
Teva
Deloitte
Accenture
McKinsey
McKesson
Healthtrust

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,595,978

« Back to Dashboard

Summary for Patent: 5,595,978
Title: Composition and method for treatment of CMV retinites
Abstract:This invention concerns compositions and methods for the treatment of CMV infections. A composition including an antisense oligonucleotide targeted to the IE2 gene of CMV and a pharmaceutically acceptable carrier were used stop progression in CMV retinitis.
Inventor(s): Draper; Kenneth G. (Boulder, CO), Chapman; Sharon K. (Carlsbad, CA), Kisner; Daniel L. (Cardiff, CA)
Assignee: Isis Pharmaceuticals, Inc. (Carlsbad, CA)
Application Number:08/233,711
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 5,595,978

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,595,978

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
PCT/US91/05815Aug 14, 1991

International Family Members for US Patent 5,595,978

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 154947 ➤ Try a Free Trial
Austria 159025 ➤ Try a Free Trial
Austria 160353 ➤ Try a Free Trial
Austria 168561 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Merck
Cerilliant
Accenture
McKesson
Citi
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.